Bio

Geoff Meyerson is CEO and Co-founder of Locust Walk. He brings a track record of success in investment banking, venture capital and licensing where he has closed >50 transactions of all varieties including playing a role in a majority of Locust Walk’s closed transactions. Prior to Locust Walk, Geoff worked in business development at a venture-backed biotech company, Zelos Therapeutics, where he was on the management team and negotiated a drug delivery collaboration with Aegis Therapeutics. Before Zelos, he worked as a venture capitalist at SR One, the venture capital subsidiary of GlaxoSmithKline, where he closed eight financings in the US and Europe. His first and most active investment where he co-lead the due diligence was for Algeta, a Norwegian radiopharma company with a product for bone metastasis. They concluded a $3B sale to Bayer, received FDA approval for their product Xofigo, and achieved a >20x return to investors. Geoff also worked at MedImmune in business development helping with their small molecule strategy, which resulted in three transactions, where he also assisted with two other transactions. He got his start as an investment banker in UBS’ Global Healthcare Investment Banking Group, where he closed 12 financing and M&A transactions with a variety of life sciences companies. He holds an MBA in Health Care Management from the Wharton School, a Masters in Biotechnology from the University of Pennsylvania, and a BS in Economics from Duke University. Geoff founded and is the President of an exclusive relationship building non-profit organization called BioBreak. BioBreak has grown to six regions internationally (Boston, San Francisco, Philadelphia, New Jersey, UK and Germany) and has a membership base of >3,000 senior life sciences operating and investing executives. He is a member of the Young Presidents Organization New England Chapter and is on the Board of Overseers for Beth Israel Deaconess Medical Center. Geoff has also served two terms on the board of the Wharton Health Care Management Alumni Association. He was named by Wharton Magazine (The Wharton School’s alumni magazine) and the Philadelphia Business Journal to their 40 Under 40 list for 2017 and 2010, respectively.